NCT05918302 2026-03-06
LEVEL
Grupo Espanol de Tumores Neuroendocrinos
Phase 3 Recruiting
Clinical Trials
7 trialsNCT06885697 2026-02-17
Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma
National Institutes of Health Clinical Center (CC)
Phase 1 Recruiting
NCT05104736 2025-09-19
PT-112 in Subjects With Thymoma and Thymic Carcinoma
National Institutes of Health Clinical Center (CC)
Phase 2 Recruiting
NCT06692062 2024-11-18
Hypofractionated Radiotherapy for Thymic Epithelial Tumors
Xiangya Hospital of Central South University
Phase NA Recruiting
NCT05683886 2024-10-17
A Study of KC1036 in Patients with Advanced Thymic Tumors
Beijing Konruns Pharmaceutical Co., Ltd.
Phase 2 Recruiting
NCT06189183 2024-02-16
Adjuvant Hypofractionation Radiotherapy for Thymic Epithelial Tumours After Complete Resection
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase NA Recruiting
NCT04822077 2021-03-30
PROTHYM
Swedish Lung Cancer Study Group
Phase NA Recruiting